Adeona Becomes Synthetic Biologics, Inc.
— New Name Reflects Biotechnology Company Focus on the Emerging Field of Synthetic Biologics — — New NYSE Amex Ticker Symbol: SYN — ANN ARBOR, Mich., Feb. 16, 2012 /PRNewswire/ — Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today that it received approval at […]
Adeona Becomes Synthetic Biologics, Inc. Read More »